Related Experiment Video
Updated: Feb 5, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
Lars E Laugsand1,2, Bjørn O Åsvold1,3, Lars J Vatten1
1Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Insights
Circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) levels do not predict coronary heart disease risk in the general population. Measuring PCSK9 adds no value beyond standard lipid measurements for assessing myocardial infarction risk.
Area of Science:
- Cardiovascular Medicine
- Biomarkers
- Epidemiology
Background:
- The role of circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) as a coronary heart disease (CHD) risk marker in the general population is not well-established.
- PCSK9 influences low-density lipoprotein cholesterol (LDL-C) metabolism, a key factor in atherosclerosis.
Purpose of the Study:
- To investigate the utility of circulating PCSK9 levels as an independent risk marker for incident myocardial infarction (MI) in a general population.
- To determine if PCSK9 provides additional risk information beyond established lipid measurements.
Main Methods:
- A nested case-control study design was employed in a Norwegian cohort.
- 1,488 incident MI cases were compared with 3,819 controls over 11.3 years of follow-up.
- Statistical analyses included adjustments for age, sex, and LDL-C levels.
Main Results:
- Higher quartiles of circulating PCSK9 were associated with increased MI risk (47% higher in the highest vs. lowest quartile) after adjusting for age and sex.
- This association was significantly attenuated after further adjustment for LDL-C.
- Circulating PCSK9 levels did not provide incremental risk prediction for MI beyond lipid measurements.
Conclusions:
- Circulating PCSK9 is not a valuable independent risk marker for myocardial infarction in the general population.
- Lipid measurements adequately capture the risk information related to PCSK9 in cardiovascular risk assessment.
Abstract:
The usefulness of circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) as a risk marker of coronary heart disease in the general population remains unclear. In a nested case-control study in Norway, 1,488 incident myocardial infarctions were registered during 11.3 years of follow-up and compared with 3,819 controls. Compared with participants in the lowest quartile of PCSK9, myocardial infarction risk was 47% higher in the highest quartile after adjustment for age and sex. After additional adjustment for low-density lipoprotein cholesterol, the association was strongly attenuated. Thus, circulating PCSK9 does not contribute useful information in the assessment of myocardial infarction risk in the general population beyond the information provided by lipid measurements.
Related Concept Videos
Relative Risk
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Overview of Pulmonary Circulation
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
Overview of Systemic and Pulmonary Circulation
The oxygenated blood is sent...

